Trials / Completed
CompletedNCT03130751
Mobile Self Management and Support for Adolescents and Young Adults With Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University of California, Los Angeles · Academic / Other
- Sex
- All
- Age
- 13 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
This study is the user testing phase of a mobile application intervention which will be designed to promote positive coping skills, illness resilience, and social support, and to serve as a complement to patient-physician interactions in adolescents and young adults (AYA) with sarcoma. User testing will be conducted with a prototype of the app. Participants will be AYA ages 13-25 with sarcoma (N=16). Study participation involves the AYAs downloading and using the app for 30 days. During the 30 days, participants will interact with the app by inputting their current mood, receiving supportive feedback from the app, reading messages, and doing brief activities (such as relaxation activities, etc.). Participants will also participate in an online focus group focused around the user experience. Before and after the 30 days of user testing, participants will complete a few brief questionnaires about their behavior, how their symptoms affect their life, and how they receive support from others. These questions will take around 20 minutes to complete at each administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Pocket Coach for AYA with Cancer | The Pocket Coach for AYA with Cancer is a psychosocial intervention to be delivered through a mobile platform. Intervention content is based on Mindfulness Based Stress Reduction (MBSR) and the Resilience in Illness Model \[Dr. Joan E. Haase et al\] and includes modules on relaxation, mindfulness, cognitions, and self-compassion. |
Timeline
- Start date
- 2017-05-23
- Primary completion
- 2017-08-10
- Completion
- 2017-08-10
- First posted
- 2017-04-26
- Last updated
- 2017-10-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03130751. Inclusion in this directory is not an endorsement.